Combination Chemotherapy With TS-1 and Cisplatin for Urinary Adenocarcinoma: A Retrospective Case Series

Clin Genitourin Cancer. 2024 Oct;22(5):102149. doi: 10.1016/j.clgc.2024.102149. Epub 2024 Jul 3.

Affiliations

¹ Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
² Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan. Electronic address: shuya79@md.tsukuba.ac.jp.
³ Department of Cardiovascular Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

PMID: 39079466
DOI: 10.1016/j.clgc.2024.102149

No abstract available

Keywords: Adenocarcinoma; Cisplatin; Rare histology; TS-1; Urinary cancer.

Publication types

Case Reports

MeSH terms

Adenocarcinoma* / drug therapy
Adenocarcinoma* / pathology
Aged
Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
Cisplatin* / administration & dosage
Cisplatin* / therapeutic use
Drug Combinations
Female
Humans
Male
Middle Aged
Oxonic Acid / administration & dosage
Oxonic Acid / therapeutic use
Retrospective Studies
Tegafur / administration & dosage
Tegafur / therapeutic use
Treatment Outcome
Urologic Neoplasms / drug therapy

Substances

Cisplatin
Tegafur
Oxonic Acid
Drug Combinations
S 1 (combination)